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All 9 patients have been on regimens designed to increase the urinary solubility of calcium oxalate, with or without the simultaneous lowering of urinary calcium and raising of urinary phosphate excretions. 8 patients have been treated for 1 -7j years (average duration 4 years) with oral magnesium hydroxide, and 2 patients have been treated with sodium phosphate. One of the latter was changed after 31 years to magnesium hydroxide and the other has been on sodium phosphate combined with a low calcium diet and cellulose phosphate continuously for 5j years. 2, not at first diagnosed as hyperoxalurics, were first given sodium bicarbonate for their presumably secondary renal tubular acidosis.
The over-all progress of the whole group is felt to have been better than could be expected from the known natural history of primary hyperoxaluria. They average 41 years on treatment during 5 years of our observation and all remain clinically well after an average of 9i years since the onset of their first symptoms. Results warrant the recommendation that, until reliable means are available to decrease oxalate overproduction, affected patients should be treated continuously with magnesium hydroxide. A more final opinion must await many more years of follow-up. The failure of several attempts to lower urinary oxalate excretion in these patients is also reported.
Primary hyperoxaluria is an inborn error of metabolism in which there is excessive production and urinary excretion of oxalate. The disease usually presents with calcium oxalate lithiasis in early childhood and runs a progressive course leading to death from renal failure with oxalosis before adult life (Hockaday et al., 1964 Dick (1967) was used. The normal 24-hour urinary oxalate output is 3-22 mg., as determined by any of these methods.
Case 1. (Peter T.) Born October 1955, the eldest of 3 affected sibs, his birth and early development were normal. His parents are unrelated.
At the age of 23 months he developed haematuria followed by brief anuria. A stone was removed from the urethral meatus, and he passed a second stone. He remained well after this episode, but 7 months later he was found to have a urinary infection with B. proteus.
When first admitted to U.C.H. in July 1958 at the age of 2 years 9 months physical examination was normal, and his height was on the 50th centile. Investigations at that time showed Hb 11 * 5 g./100 ml.; plasma urea and electrolytes were normal apart from a bicarbonate level of 21 * 4 mMol/l., and plasma calcium, phosphorus, and alkaline phosphatase were also normal. Urine examination showed persisting infection with B. proteus. 24-hour calcium excretion was 49 mg. and an amino acid chromatogram was normal. 24-hour oxalate excretion was recorded at only 22 mg.; however, after a divided oral load of sodium oxalate 140 mg., his simultaneous 24-hour oxalate excretion increased to 42 mg. Radiology revealed bilateral renal stones and a staghom calculus on the right side. He was able to acidify his urine to a minimum pH of 5 *2 after an ammonium chloride load. His urinary infection was successfully treated with sulphonamides and he was discharged on long-term sulphonamide therapy. At that time it was thought that a metabolic cause for his stones had been excluded. He was readmitted to U.C.H. in July 1962 aged 6 years 9 months for reappraisal after the discovery that his sister (Case 2), born in November 1958, had hyperoxaluria. He was well and had grown up to the 75th centile. Blood and urine investigations revealed no abnormality except his 24-hour urine oxalate excretion which ranged between 50 and 196 mg. Radiology showed a small stone in the left kidney. Previous medication was stopped, and treatment was begun with light magnesium oxide 210 mg. daily; for a short time a low calcium diet was also given. Fig. 1 shows his urinary excretion of calcium, magnesium, and oxalate during this admission. It illustrates the typical rise in urinary magnesium which occurs when oral magnesium is given, and also shows the effect of a low calcium diet on reduction of urinary calcium. Urinary oxalate does not change notably and continues to fluctuate widely. He was discharged for long-term follow-up on magnesium hydroxide mixture (B.P.) 4 ml. q.i.d. as sole treatment.
He has remained well since then apart from a few mild episodes of haematuria in 1964 associated with a small additional stone in the left ureter which subsequently disappeared. Further x-rays have shown no change ( Fig. 2a and b (Fig. 3a-c) as it seemed possible that it was this latter complication that was now the cause of the continuing deterioration. Plasma urea, electrolytes, urate, and creatinine have remained normal. Her height has grown up to between the 10th and 25th centile, and her weight has increased to between the 3rd and 10th centile. He was first seen at U.C.H. in August 1965 aged 5 months, when physical examination was normal. His height was on the 50th centile, and his weight just above the 90th. Investigation at that time showed Hb 11.5 g./100 ml., plasma levels of calcium, urea, and electrolytes were normal. Urine examination showed no abnormality apart from numerous oxalate crystals; the 24-hour urine calcium excretion was 30-37 mg., and oxalate excretion 32-34 mg. Radiology revealed 3 small areas of calcification in the left kidney.
On thus confirming the expected diagnosis treatment was begun with magnesium hydroxide (B.P.) 2 ml. q.i.d. and he was discharged for long-term follow-up. Between December 1965 and January 1966 he passed several stones and suffered haematuria, but has remained well since that time, with the exception of several days haematuria in September 1968, aged 3i. Radiology has shown minimal enlargement of one left renal stone.
Plasma urea, electrolytes, urate, and creatinine levels remain normal.
Case 4. (Robert C.) Born September 1955, the 3rd child of unrelated parents, his birth and early development were normal, and there was no relevant family history.
At the age of 2 years 7 months he developed persistent haematuria and passed 3 stones, the attack resolving in about 2 days. At the age of 3 years exactly he developed acute anuria requiring the removal of 12 stones from his urethra. He had no other symptoms. Investigation at that time revealed bilateral nephrocalcinosis.
When first admitted to U.C.H. in July 1959 at the age of 3 years 10 months, physical examination revealed no abnormality apart from mild knock-knees; his height and weight were on the 50th centile. All blood investigations at that time were interpreted as normal. Urine examination showed no protein, variable numbers of red and white cells, and the presence of calcium oxalate crystals, and was sterile on culture. 24-hour calcium He was first seen at U.C.H. in March 1964 at the age of 14. He was well apart from his urinary symptoms and physical examination revealed only his previous surgical scars. His blood pressure was 120/60 mm. Hg and his height and weight were normal for his age. Investigations at that time showed normal haemoglobin, plasma urea, and electrolytes, urate, calcium, phosphorus, and alkaline phosphatase. Urine examination showed a trace of protein, 3 to 5 white and 8 to 10 red blood cells per high power field, and was sterile on culture. The overnight urine specific gravity was 1020 and the urine diluted after a waterload to a specific gravity of 1003. 24-hour calcium excretion was 74 mg. and an amino acid chromatogram was normal. The 24-hour oxalate excretion was 135-222 mg. Radiology revealed a generally dense skeleton and dense bilateral renal calculi.
Successive short trials were performed with oral D-L glutamic acid 20 g. daily, and disodium hydrogen phosphate 10 g. daily, but no effect on the 24-hour urinary oxalate excretion was seen. He was finally begun on a low calcium diet (400 mg. daily) with cellulose phosphate 5 g. t.d.s. which produced a satisfactory fall in calcium excretion from 75-200 mg. to 42-57 mg. He was discharged for long-term follow-up on this regimen which included a 3-litre fluid intake, and two months later disodium hydrogen phosphate 2 g. 5 times daily was added.
His clinical progress during the 6-year follow-up has shown an obvious improvement. In spite of a few setbacks he has been especially active physically, sailing in the summer and skiing and mountaineering. He underwent left ureterolithotomy in November 1965 after the progressive slight enlargement of a single stone. Since that time he has passed only 2 stones and radiology has shown no change apart from questionable minimal enlargement of calculi on the right side. He has noticed occasional haematuria over a short period in 1966, and again in 1969 accompanied by colic before the passage of one stone. Plasma electrolyte, urea, calcium, and phosphorus levels have remained normal throughout. Plasma urate levels have risen from 5-3 mg./100 ml. in 1967 to 8-3 mg./100 ml. in 1968/69. He has also shown an unexplained polycythaemia with haemoglobin levels up to 18-7 g./100 ml. (16-5 g./100 ml. at present). Skeletal x-rays have shown good growth and maintenance of bone density.
Case 6. (Neil T.) Born August 1957, the second child of a first cousin marriage, his birth and early development were normal apart from fretful episodes in infancy.
At the age of2 years 6 months he developed haematuria and abdominal pain, and a stone was demonstrated radiologically in the right ureter. The stone was later passed. He had further pain and haematuria the same year and a left ureteric calculus was passed which consisted of pure calcium oxalate. Between the ages of 5 and 8 he had at least 5 attacks of colic or haematuria and the passage of a stone was demonstrated clinically or radiologically on three separate occasions. He At the age of 11 months he developed haematuria, and at the age of 2 years precisely 3 large stones in the right kidney and 1 large stone in the left renal pelvis were demonstrated radiologically. The left stone was removed and found to consist of pure calcium oxalate. During the subsequent 4 months he had intermittent haematuria and one severe attack.
When first admitted to U.C.H. in May 1966 aged 2 years 5 months he appeared well, and physical examination showed no abnormality apart from his healed surgical scar. His height and weight were both between the 25th-50th centiles. Investigations at that time showed normal haemoglobin, urea, and electrolytes, urate, calcium, phosphorus, and alkaline phosphatase. Urine examination showed a trace of protein, occasional white and numerous red blood cells, and was sterile. 24-hour calcium excretion was 31-81 mg., and an amino acid chromatogram was normal. 24-hour oxalate excretion ranged between 17-107 mg. Radiology revealed 3 large stones in the right kidney.
He was treated altematively with neomycin 0-25 g. (Fig. 5a and b) . However, since the end of 1969 urine examination has revealed a persistent infection with B. proteus, and surgical removal ofhis renal stones is being contemplated. His height and weight have continued to grow between the 25th and 50th centiles. In the first 7 months after his discharge he suffered two attacks of urinary infection. He had one attack of renal colic followed by the passage of a stone in April 1969, and passed one small stone without difficulty in January 1970. He is otherwise well. Radiology has shown the appearance of new small stones, and his urine shows occasional red cells. Renal tubular acidosis has been excluded by a normal response to an ammonium chloride load.
Discussion
The biochemical basis of primary hyperoxaluria has recently been extensively reviewed by Williams and Smith (1968a) , and will only be summarized here. There are two forms of the disease both of which are transmitted by an autosomal recessive gene. The metabolic block leading to oxalate overproduction in the commoner form (Type 1) is represented in Fig. 6 . Koch et al. (1967) have shown the deficient enzyme to be a-ketoglutarate: glyoxylate carboligase. In addition to excess oxalate patients also excrete excess glycollic and glyoxylic acid (Hockaday et al., 1965) . 6 of our patients (Cases 4-9) probably have this classic form. Williams and Smith (1968b) have recently described 4 patients with a genetic variant (Type 2), clinically indistinguishable from the main form, which is associated with L-glyceric aciduria instead of glycollic aciduria. The direct cause of hyperoxaluria in these patients is not fully understood. 3 of the 4 patients they studied are the sibs (Cases 1-3) described in more detail in the present report.
The natural history of primary hyperoxaluria has been summarized from the literature and described by Hockaday et al. (1964) . Most of these cases have not been tested for L-glyceric aciduria but few would presumably have this rare variant. The disease usually presents with oxalate lithiasis in early childhood and runs a progressive course leading to death from renal failure before adult life. The uraemic phase is usually short and associated with a fall in urinary oxalate levels, which then leads to the deposition of oxalate crystals throughout the body, thus producing terminally the condition of oxalosis. A minority of patients may present with chronic renal failure.
The onset of symptoms occurs before the age of 5 in approximately 65% of patients, and 80% die before they reach the age of 20. Prognosis is worse the earlier the age of onset. Rarely atypical cases may not present before early adult life and may run a relatively benign course. The possible benefit of any therapeutic regimen is difficult to assess since comparison with published series is restricted by the need to relate results not only to the age of onset but also to the length of follow-up. A further difficulty in assessing the prognosis of patients under observation arises from the restriction of the survey of Hockaday et al. (1964) Smith and Williams, 1967. follow-up. Thus of 40 typical cases presenting before the age of 5, 20 (50%) had died after an average follow-up of 8 years (ranging from early death to living after 26 years). Of the 8 patients described by Hall, Scowen, and Watts (1960) , 3 had died within 5 years of the onset of their first symptoms, and 2 were stone free and symptom free after 1 and 4 years. By contrast all patients in the present series are alive and clinically well after an average period of 9 years since first presentation. First symptoms occurred before the age of 5 in 8 of our 9 patients and before the age of 3 in 7. Only Case 4 was nearly adult before his first symptom and is thus atypical. Some of the data on these patients are summarized in the Table. They have all been under regular follow-up at intervals of 4 to 6 months since their first presentation, and at each attendance have had measurements of their 24-hour urine calcium, magnesium, and oxalate excretions.
Urinary oxalate in all our later studies after 1965 was measured by Dick's (1967) modification of the method of Archer et al. (1957) ; the normal range of daily oxalate excretion in 15 adults was 3-22 mg.
Results by this method agree closely with that of Hodgkinson and Zarembski (1961) which was mainly used earlier in this study . Hockaday et al. (1965) using an isotope dilution technique have shown that normal values in children are similar to adults when corrected for body surface area. The level of oxalate excretion in our patients does not appear to be related to the clinical course of the disease, a finding previously noted by Hall et al. (1960) . Moreover it has fluctuated widely during follow-up, and twofold or even threefold changes have been found in consecutive specimens.
It is of interest that our two patients with nephrocalcinosis (Cases 1 and 7) have also had incomplete renal tubular acidosis (Wrong and Davies, 1959) , as judged by defective urinary acidification after an ammonium chloride load. They were in fact first diagnosed and treated on this basis with sodium bicarbonate. Features suggestive of renal tubular acidosis have previously been noted in hyperoxaluria (Williams and Smith, 1968a Neither has met with long-term success (Archer et al., 1958; Swartz and Israels, 1963) . The feeding of D-amino acids to compete with glycine for D-amino acid oxidase (glycine oxidase) has also been attempted without success ; we gave D-L glutamic acid, 20-40 g. daily, to Case 9, without significant response. The same patient also received L-histidine on an empirical basis without effect. The aldehyde dehydrogenase inhibitor calcium carbimide was found by Solomons and his coworkers (Solomons, Goodman, and Riley, 1967) to lower oxalate excretion in one patient who received a kidney transplant, local irradiation, and corticosteroid therapy. However, no consistent effect was found during another study in three patients (Zarembski, Hodgkinson, and Cochran, 1967) . Two of our patients (Cases 4 and 5) also received calcium carbimide (50 mg. b.d.) for 4 days without effect on oxalate excretion. Another aldehyde dehydrogenase inhibitor, tetraethylthiuram disulphide (disulfiram) was employed by Gibbs and Watts (1967) without effect, and our Case 4 also received the drug for 4 days without success. The administration of pyridoxine has been shown to reduce oxalate excretion both in certain groups of non-hyperoxaluric subjects (Gershoff, 1964) and in some patients with hyperoxaluria , but this has not been a consistent finding (Gibbs and Watts, 1967) , and we have not been able to show an effect in one patient (Case 4) given the vitamin in the very large dosage of 100 mg. five times daily. On a purely empirical basis, we wondered if the administration of an intermediate, or derivative, of the tricarboxylic acid cycle would divert glyoxylate from oxalate synthesis. Malonate
(1 * 5-3 *O g. daily) and valine, which is converted to methyl malonate (6 g. daily), was administered to Case 3. Both compounds were without effect.* A major problem in short-term studies of oxalate excretion is the wide day-to-day fluctuation in urinary oxalate levels, which occurs even when diet, activity, etc. are closely standardized. This makes baseline determination very uncertain. Further understanding of this phenomenon could well lead to a more successful therapeutic approach.
We have followed the alternative line of treatment in our attempts to increase oxalate solubility in urine by the use of magnesium (in 8 patients) or phosphate (2 patients). Details are summarized in the Table. The presence of magnesium has long been known to prevent quantitative precipitation of calcium oxalate in vitro, and magnesium administration has more recently been found to inhibit oxalate stone formation in rats made hyperoxaluric both by pyridoxine deficiency (Lyon et al., 1966) and by ethylene glycol poisoning (Borden and Lyon, 1968-69) . Combined pyridoxine and magnesium therapy has successfully prevented recurrent oxalate stone formation in patients not suffering from hyperoxaluria (Gershoff and Prien, 1967) . Of our patients treated with magnesium hydroxide mixture (B.P.) in varying dosage (see Table) , all are clinically well, 2 have improved, 3 have had all deterioration halted, and 3 show only minor radiological evidence of an increase in urinary tract calcification (Fig. 2-5) .
A high phosphate intake has also been claimed to be of benefit in preventing urinary stone formation. This may be related in part to a decrease in urine calcium excretion, and in part to an increase in urinary levels of pyrophosphate and certain protective polypeptides (Howard and Thomas, 1968) . Williams and Smith (1968a) treatment cannot be considered curative in primary hyperoxaluria, it does appear that with such management the previous gloomy prognosis in this condition may be improved. Longer follow-up of our patients is required for a final opinion.
